Navigation Links
Schering-Plough Announces Transition of Animal Health Leadership
Date:10/17/2008

Schering-Plough over the past year," said Hassan. "I thank Ruurd for his leadership, guidance and important contributions bringing our two companies together. Raul and I look forward to working with him in an advisory capacity."

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.

Media Contact

Steve Galpin, Jr.

+1 908 298 7415

Sabine Schueller

+31 485 58 7085

Investor Contacts

Janet Barth

Joseph Romanelli

+1 908 298 7436


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
2. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
3. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
4. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
5. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
6. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
7. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
8. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
9. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
10. Schering-Plough CEO to Buy $2 Million in Common Shares
11. Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Anesiva Receives NASDAQ Listing Compliance Notice 2Health News:Anesiva Receives NASDAQ Listing Compliance Notice 3Health News:Frost & Sullivan to Hold Web Conference on Integrated Hospital Pharmacy Information Systems - How to Maneuver towards Growth Potential 2Health News:FramesDirect.com Has Record-Breaking Sales on Black Friday and Cyber Monday 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2
Other Medicine News:Health News:RxPop.com Announces Corporate Sponsorships with Several of the Nation's Leading Health Charities 2Health News:RxPop.com Announces Corporate Sponsorships with Several of the Nation's Leading Health Charities 3Health News:CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study 2Health News:CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study 3Health News:CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study 4Health News:CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study 5Health News:CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study 6Health News:Figure Skater Peggy Fleming Teams with HealthSaver: Heart Healthy Living 2Health News:Figure Skater Peggy Fleming Teams with HealthSaver: Heart Healthy Living 3Health News:Figure Skater Peggy Fleming Teams with HealthSaver: Heart Healthy Living 4Health News:Figure Skater Peggy Fleming Teams with HealthSaver: Heart Healthy Living 5Health News:2007 Ottawa & Eastern Ontario Physique Championship to be Sponsored by Natural Nutrition 2Health News:AZoOptics.com - The A to Z of Optics Launched By AZoNetwork 2Health News:Lose Weight, Conquer World Hunger with www.DonateYourCalories.com 2